Camptothecin-loaded films for the prevention of postsurgical adhesions

Inflammation Research

Volumn 53, Issue 8, 2004, Pages 355-362

  Cashman, J ^a   Burt, H M ^a   Springate, C ^a   Gleave, J ^a   Jackson, J K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Camptothecin; Hyaluronic acid films; Surgical adhesions

Indexed keywords

ANTIINFLAMMATORY AGENT; CAMPTOTHECIN; HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; FILM; NONHUMAN; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; RAT; SURGICAL INJURY; TISSUE ADHESION;

EID: 4344572613     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-1272-2     Document Type: Article

References (54)

1. Ellis H. The cause and prevention of postoperative intraperitoneal adhesions. Surg Gynecol Obstet 1971; 133: 497-511.
2. Wiebel MA, Majno G. Peritoneal adhesions and their relation to abdominal surgery. Am J Surg 1973; 126: 345-53.
3. diZerega GS. Biochemical events in peritoneal tissue repair. Eur J Surg 1997; 163 (Suppl. 577): 10-6.
4. diZerega GS. The cause and prevention of postsurgical adhesions: a contemporary update. Prog Clin Biol Res 1993; 381: 1-18.
5. Luijendijk RW, deLange DCD, Wauters CC, Hop AC, Duron JJ, Pailler JL et al. Foreign material in postoperative adhesions. Ann Surg 1996; 223: 242-8.
6. Diamond MP, Hershlag A. Adhesion formation/reformation. Prog Clin Biol Res 1990; 358: 23-33.
7. Diamond E. Lysis of postoperative pelvic adhesions in infertility. Fertil Steril 1979; 31: 287-95.
8. Stout AL, Steege JF, Dodson WC, Hughes CL. Relationship of laparoscopic findings to self-report of pelvic pain. Am J Obstet Gynecol 1991; 146: 73-9.
9. Beck DE, Opelka FG, Bailey HR, Rauh SM, Pashos CL. Incidence of small-bowel obstruction and adhesiolysis after open colorectal and general surgery. Dis Colon Rectum 1999; 42: 241-8.
10. Menzies D, Ellis H. Intestinal obstruction from adhesions-how big is the problem? Ann R Coll Surg Engl. 1990; 72: 60-3.
11. Wilson MS, Menzies D, Knight AD, Crowe AM. Demonstrating the clinical and cost effectiveness of adhesion reduction strategies. Colorectal Disease 2002; 4: 355-60.
12. Coleman MG, McLain AD, Moran BJ. Impact of previous surgery on time taken for incision and division of adhesions during laparotomy. Dis Colonb Rectum 2000; 43: 1297-9.
13. Ray NF, Larsen JW, Stillman RJ, Jacobs RJ. Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993; 176: 271-6.
14. Ray NF, Denton WG, Thamer M, Henderson SC. Abdominal adhesiolysis: Inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998; 186: 1-9.
15. Shimanuki T, Nakamura RM, diZerega GS. A kinetic analysis of peritoneal fluid cytology and arachidonic acid metabolism after abrasion and reabrasion of the rabbit peritoneum. J Surg Res 1986; 41: 245-51.
16. Abe H, Rodgers KE, Ellefson D, diZerega GS. Kinetics of interleukin 1 and tumor necrosis factor secretion by rabbit macrophages recovered from the peritoneal cavity. J Invest Surg 1991; 4: 141-51.
17. Steinleitner A, Lambert H, Henderson S. New modalities under development for adhesion prevention: immunomodulatory agents and poloxamer barrier materials. In: Diamond MP et al. (eds): Gynecological Surgery and Adhesion Prevention. New York: Wiley-Liss, 1993: 235-51.
18. Holmdahl L, Ivarsson ML. The role of cytokines, coagulation and fibrinolysis in peritoneal tissue repair. Eur J Surg 1999; 65: 1012-9.
19. Pijlman BM, Dorr PJ, Brommer EJ, Vemer HM. Prevention of adhesions:review. Eur J Obstet Gynecol Reprod Biol 1994; 53: 155-63.
20. diZerega GS. Contemporary adhesion prevention. Fertil Steril 1994; 61: 219-35.
21. diZerega GS, Hodgen GD. Prevention of postoperative tubal adhesions: comparative study of commonly used agents. Am Obstet Gynecol 1980; 136: 173-8.
22. Sanfilippo JS, Cox JG, Nealon NA, Barrows GH. Comparisons of corticosteroid therapy in the prevention of pelvic tissue reaction and adhesion formation. Int J Fertil 1986; 30: 57-61.
23. Grosfeld JL, Berman IR, Schiller M, Morse TS. Excessive morbidity resulting from the prevention of intestinal adhesions with steroids and antihistamines. J Pediatr Surg 1973; 24: 935-40.
24. LeGrand EK, Rodgers KE, Girgis W, Campeau JD, diZerega GS. Comparative efficacy of nonsteroidal anti-inflammatory drugs and anti-thromboxane agents in a rabbit adhesion-prevention model. J Invest Surg 1995; 8: 187-94.
25. Rodgers KE, Girgis W, diZerega GS, Bracken K, Richer L. Inhibition of postsurgical adhesions by liposomes containing nonsteroidal anti-inflammatory drugs. Int J Fertil 1990; 35: 315-20.
26. Nishimura K, Shimanuki T, diZerega GS. Ibuprofen in the prevention of experimentally induced postoperative adhesions. Am J Med 1984; 77: 102-6.
27. Hellebrekers BW, Trimbos-Kemper TC, Trimbos JB, Emeis JJ, Kooistra T. Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fert Steril 2000; 74: 203-12.
28. Knightly JJ, Agostino D, Cliffton EE. The effect of fibrolysin and heparin on the formation of peritoneal adhesions. Surgery 1962; 52: 250-7.
29. Rivkind AI, Lieberman N, Durst AL. Urokinase does not prevent abdominal adhesion formation in rats. Eur Surg Res 1985; 17: 254-8.
30. James DC, Ellis H, Hugh TB. The effect of streptokinase on experimental intraperitoneal adhesion formation. J Pathol Bact 1965; 90: 279-87.
31. Nordic Adhesion Prevention Study Group. The efficacy of Interceed (TC7)* for prevention of reformation of postoperative adhesions on ovaries, fallopian tubes, and fimbriae in microsurgical operations for fertility: a multicenter study. Fertil Steril 1995; 63: 709-14.
32. Myomectomy Adhesion Multicenter Study Group. An expanded polytetrafluoroethylene barrier (Gore-Tex Surgical Membrane) reduces post-myomectomy adhesion formation. Fertil Steril 1995; 63: 491-3.
33. Diamond MP. The Seprafilm Adhesion Study Group. Reduction of adhesions after uterine myomectomy by Seprafilm™ (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Fert. Steril 1996; 66: 904-10.
34. Becker JM, Dayton MT, Fazio VW, Beck DE, Stryker SJ, Wexner SD et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: A prospective randomized, double-blind multicentre study. J Am Coll Surg 1996; 183: 297-306.
35. Larsson B, Lalos O, Marsk L, Tronstad SE, Bygdeman M, Pehrson S et al. Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstet Gynecol Scand 1985; 64: 437-41.
36. Elkins TE, Bury RJ, Ritter JL, Ling FW, Ahokas RA, Homsey CA. Adhesion prevention by solutions of sodium carboxymethylcellulose in the rat. Fertil Steril 1984; 41: 926-8.
37. Gist RS, Lu PY, Raj HG, Campbell C, Elkins TE. Use of sodium hetastarch (Hespan) solution for reduction of postoperative adhesion formation in rabbits. J Invest Surg 1996; 5: 369-73.
38. diZerega GS, Verco SJ, Young P, Kettel M, Kobak W, Martin D et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod 2002; 17: 1031-8.
39. Gauwerky JF, Heinrich D, Kubli, F. Complication of intraperitoneal dextran application for prevention of adhesions. Biol Res Pregnancy Perinatol 1986; 7: 93-7.
40. Jansen RPS. Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. Am J Obstet Gynecol 1985; 153: 363-71.
41. Rowinsky EK, Cazenave LA, Donehower RC. Review: Taxol®: A novel investigational antimicrotubule agent. J Natl Cancer Inst 1990; 82: 1247-59.
42. Burt HM, Jackson JK, Bains SK, Liggins RT, Oktaba AM, Arsenault A et al. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,1-lactic acid). Cancer Lett 1995; 88: 73-9.
43. Jackson JK, Skinner KC, Burgess L, Sun T, Hunter WL, Burt HM. Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm Res 2002; 19: 411-7.
44. Ulukan H, Swaan PW. Camptothecins: a review of their chemotherapeutic potential. Drugs. 2002; 62: 2039-57.
45. Clements M, Jones C, Cummings M, Daoud S. Antiangiogenic potential of camptothecin and topotecan. Cancer Chemother Pharmacol 1999; 44: 411-6.
46. Pommier Y, Pourquier P, Fan Y, Strumberg D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta 1998; 1400: 83-105.
47. Hopkins MP, von Gruenigen VE, Holda S, Weber B. The effect of intermittent-release intraperitoneal chemotherapy on wound healing. Am J Obstet Gynecol 1997; 176: 819-23.
48. Tudan C, Jackson JK, Higo TT, Burt HM. The effect of inhibiting topoisomerase I and II on the anti-apoptotic response associated with pro-inflammatory crystals of calcium pyrophosphate dihydrate in human neutrophils. Inflamm Res 2003; 52: 8-17.
49. Czuwara-Ladykowska J, Makiela B, Smith EA, Trojanowska M, Rudnicka L. The inhibitory effects of camptothecin, a Topoisomerase I inhibitor on collagen synthesis in fibroblasts from patients with systemic sclerosis. Arthritis Res 2002; 3: 311-8.
50. Kim KJ, Li B, Winter J, Armanini M, Gillett N, Philips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis-suppressed tumor growth in vivo. Nature 1993; 362: 841.
51. Mariani AR, Columbaro M, Zauli G, Zamai L, Luchetti F, Gobbi P et al. Lineage-related susceptibility of human hemopoietic cell lines to apoptosis. Anat Res 1999; 254: 1-6.
52. Ferraro C, Quemeneur L, Fournel S, Prigent AF, Revillard JP, Bonnefoy-Berard N. The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes. Cell Death Differ 2000; 7: 197-206.
53. Holmdahl L, Risberg B, Beck DE, Burns JW, Chegini N, diZerega GS et al. Adhesions: Pathogenesis and prevention-panel discussion and summary. Eur J Surg 1997; Suppl 577: 56-62.
54. Vercruysse KP, Marecak DM, Maracek JF, Prestwich GD. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjugate Chem 1997; 8: 686-94.